Filing Details

Accession Number:
0001209191-20-018736
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-13 12:19:45
Reporting Period:
2020-03-12
Accepted Time:
2020-03-13 12:19:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367920 Concert Pharmaceuticals Inc. CNCE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1377820 G Thomas Auchincloss C/O Concert Pharmaceuticals, Inc.
65 Hayden Avenue, Suite 3000N
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-12 1,500 $8.52 6,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.50 to $8.547, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.